Detalhe da pesquisa
1.
Longitudinal profiling identifies co-occurring BRCA1/2 reversions, TP53BP1, RIF1 and PAXIP1 mutations in PARP inhibitor-resistant advanced breast cancer.
Ann Oncol
; 35(4): 364-380, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38244928
2.
Current and future diagnostic and treatment strategies for patients with invasive lobular breast cancer.
Ann Oncol
; 33(8): 769-785, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35605746
3.
Corrigendum to "Current and future diagnostic and treatment strategies for patients with invasive lobular breast cancer": [Annals of Oncology 33 (2022) 769-785].
Ann Oncol
; 34(3): 326, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36529568
4.
Modelling the Cancer Phenotype in the Era of CRISPR-Cas9 Gene Editing.
Clin Oncol (R Coll Radiol)
; 32(2): 69-74, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31679912